Article
Whole exome sequencing identifies the first STRADA point mutation in a patient with polyhydramnios, megalencephaly, and symptomatic epilepsy syndrome (PMSE).
American journal of medical genetics. Part A - 1 Aug 2016
Bi Weimin, Glass Ian A, Muzny Donna M, Gibbs Richard A, Eng Christine M, Yang Yaping, Sun Angela
Abstract excerpt
Polyhydramnios, megalencephaly, and symptomatic epilepsy syndrome (PMSE) is an ultra rare neurodevelopmental disorder characterized by severe, infantile-onset intractable epilepsy, neurocognitive delay, macrocephaly, and craniofacial dysmorphism. The molecular diagnosis of this condition has thus far only been made in 16 Old Order Mennonite patients carrying a homozygous 7 kb founder deletion of exons 9-13 of...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
